Lower Urinary Tract Symptoms Clinical Trial
Official title:
Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase
Rationale:
The sensation of the need for urination (urge) is a complex and only partially understood
mechanism. It is our hypothesis that this mechanism is disrupted in patients suffering from
overactive bladder syndrome.
The Overactive Bladder syndrome (OAB) has been defined as a spectrum of symptoms in which
incontinence may or may not overlap with urgency, frequency and nocturia. This syndrome is
estimated to affect approximately 17% of the adult population in Europe and the United
States. The symptoms of overactive bladder have many potential causes and contributing
factors. One of these factors is an outlet obstruction of the bladder due to benign
prostatic hyperplasia (BPH). Nowadays antimuscarinic drugs are used for treatment of the
overactive bladder. Antimuscarinic agents have been proven to work slightly to moderately
better than placebo's and are associated with side effects such as a dry mouth, blurred
vision and constipation.
Many patients with lower urinary tract symptoms (LUTS) develop OAB. In this group of
patients with LUTS and OAB, there is not always a clear obstruction found. So, at least in
some patients, with LUTS, there must be another reason for OAB than obstruction.
The autonomous bladder activity has been introduced by, among others the Maastricht Urology
research group. In animal models, the bladder is shown to have rhythmic low amplitude
contractions (micro motions). It is hypothesized that this activity has a sensory function
in the micturation regulation system which is mainly located in the bladder wall. These so
called micromotions have never been demonstrated in the human bladder. The sensing function
of the bladder and the micturation reflex remain mainly unclear. We hypothesise that there
is a disregulation of the autonomous bladder activity (micro motions) in patients with OAB.
We want to explore and study the relationship between OAB, obstruction and the micro motions
in order to gain a better understanding of the bladder (patho)physiology. reason for This on
its turn, can help us in the quest for better treatment strategies for patients suffering
from OAB.
Objective:
The study is divided in two distinct groups a male and female group:
The male group consist of patients with lower urinary tract symptoms (LUTS). The female
group consist of patients with the overactive bladder syndrome OAB.
The primary objective of this pilot experiment is to describe via an observational study the
relation between non-micturation bladder activity and sensation during the filling phase of
the bladders in women. We want to explore if there is a relation between non-micturation
bladder activity and the sensation of urgency during the filling phase.
Furthermore in men, we want to study the relationship between non-micturation bladder
activity and the amount of obstruction.
We would also like to visualize the micro motions of the bladder in both men and women
during filling phase and study the influence of (visual and cognitive) stimuli on bladder
activity.
We want to explore if there is a relation between non-micturation bladder activity and the
sensation of urgency during the filling phase in male patients with Lower urinary tract
symptoms. In order to gain a better understanding in bladder (patho)physiology.
Study design: A pilot observational study to describe the non-micturation bladder activity
and sensation measurement during filling phase.
Study population:
The study population consists of two groups. First a group of patients (female) who will
undergo an ambulatory urodynamic investigation to investigate their bladder complaints. All
patients will be older than 18 years.
The second group consists of male patients who will undergo a conventional urodynamic
investigation in the normal work up for their lower urinary tract symptoms. All patients
will be older than 18 years.
Importance of the problem:
Incontinence, increased urge and increased frequency of micturition affect nearly 100
million people in the western world 1,2 (33 million in the US and 66 million in the European
Union). These conditions are not life threatening but they seriously affect quality of life
and ability to work. OAB is in some studies reported to have an incidence of up to 17 % in
the western population with great consequences for the quality of life.
The lower urinary tract symptoms (LUTS) are more prevalent in the older population, where
40% over the age of 70 years are affected. Therefore, LUTS represent major problems to
individuals, health professions and society. Importantly, as people are generally living
longer, the numbers affected by LUTS are increasing.
Economic cost:
The total economic cost of this group of conditions is high. In 2002 the costs in the US
were approximately $12.7 billion1 (estimated to be $17 billion and €22 billion/year in
2005). Approximately 25% of this expenditure is spent on treatment (drug therapy, clinical
consultation and surgery). Of those who suffer only 28% have sought help and only half of
those currently receive treatment. Less than 3% regain long lasting normal control.
Therefore, these costs are an under-estimate and the problem is large.
Aetiology:
The primary clinical problem in the overactive bladder syndrome is an increased urge to pass
urine, with or without incontinence. Remarkably, despite the prevalence and costs involved,
the mechanisms underlying increased urge are not known. In order to simply describe the
condition the term 'Over Active Bladder (OAB) Symptom Complex' has been introduced. In many
cases, studied using conventional urodynamics, sensations of urge are correlated with rises
in intra-vesical pressure, a condition classified as detrusor over activity (DO). In the
remainder of patients, sensation is not accompanied by pressure changes and the condition
can be described as bladder over activity (BO), previously described as sensory urgency.
These differences in the relationship between sensation and bladder activity may be
indicative of different clinical states. However, it is more likely that we don't yet
understand the nature of the clinical condition.
Lower urinary tract symptoms are mostly caused by obstruction which is often caused by
benign prostatic hypertrophia (BPH).
The study will be conducted among two distinct groups. a male and a female group.
The Female group:
In the female group the patients will be asked to describe their complaints while standard
ambulatory urodynamic investigation takes place. Patients are asked to spend one hour of the
six hours time which is the normal time for ambulatory urodynamics with us in the clinic.
During this time patients are asked to sit or stand up right and answer a few questions
about their bladder sensations. Normally patients are free to go home and with this study
these women are asked to spend the first hour in our clinic.
Patients will be asked to fill in a self-consciousness questionnaire in the period around
the urodynamic measurement. They can do that before or after the measurement at home. This
will take about 10 minutes.
Patients will also be asked to think of the answer to a few questions shown on a computer
screen, during the urodynamic measurements. They will also be shown a few pictures, e.g.
toilets or landscape pictures.
After obtaining informed consent, at the beginning of the normal procedure for a ambulatory
urodynamic measurement the vesical catheter which is inserted in the patient for the purpose
of the ambulatory urodynamic measurement will be connected to a more sensitive measuring
device (PASAQ) with a 601 certification, designed by the IDDEE department of the Maastricht
university and approved by the Maastricht university hospital technical department. (Mr.
Frank Meeuwissen).
The bladder of the patient will be filled physiologically by the kidneys after drinking
fluids, we will measure with a high sensibility, and try to study the small bladder
contractions.
At intervals of 15 minutes the patient will be shown a computer screen on which 2 questions
will be written. (e.g. Do you have a desire to void now?) the patient does not need to
answer that question. We hypothesize that thinking of this question will trigger very small
bladder contractions which allows the brain to , feel ' the bladder filling. The patient
will also be shown a few pictures (e.g. a toilet and a landscape picture) in order to assess
the effect of , and the difference between these visual stimuli on bladder contraction.
The male group:
In the study of male patients who are undergoing a standard stationary urodynamic
measurement in the normal diagnostic work for their lower Urinary tract symptoms are asked
to take part in the study.
This means that the measurement will take some 10 minutes more and that they are asked to
fill in a questionnaire. There will be no extra catheter insertion or any invasive
measurements added to the normal procedure of the conventional urodynamic measurements which
they are undergoing for their symptoms.
Patients will be asked to fill in a self-consciousness questionnaire in the period around
the urodynamic measurement. They can do that before or after the measurement at home. This
will take about 10 minutes.
Patients will also be asked to think of the answer to a few questions shown on a computer
screen, during the urodynamic measurements. They will also be shown a few pictures, e.g.
toilets or landscape pictures.
We want to study the effect of such a visual or cognitive stimuli on the bladder
contraction.
After obtaining informed consent, at the end of the normal procedure for a conventional
urodynamic measurement the vesical catheter will remain in the patient for about ten minutes
longer. This catheter is then connected to a more sensitive measuring device (PASAQ) with a
601 certification, designed by the IDDEE department of the Maastricht university and
approved by the Maastricht university hospital technical department. (Mr. Frank Meeuwissen).
The bladder of the patient will be filled just like in a normal urodynamic measurement up to
3 different fillings, 100, 200 and 300 ml. At each of these filling amounts, the pomp will
be stopped during 2 minutes and we will measure with a high sensibility, and try to study
the small bladder contractions. At the 300 ml filling the patient will be shown a computer
screen on which 2 questions will be written. (e.g. Do you have a desire to void now?) the
patient does not need to answer that question. We hypothesise that thinking of this question
will trigger very small bladder contractions which allows the brain to , feel ' the bladder
filling. The patient will also be shown a few pictures (e.g. a toilet and a landscape
picture) in order to assess the effect of , and the difference between these visual stimuli
on bladder contraction.
Main study parameters/endpoints:
In the female group the main study parameters will be to characterize non-micturition
activity during bladder filling in relation to visual and cognitive stimuli. This new high
definition device will allow us to measure small an delicate changes in bladder pressure and
allow us to relate this activity to bladder volume and sensation, to determine the nature of
any change in this activity associated with OAB. The secondary study parameters are to
identify possible mechanisms underlying OAB, to explore the possibility that therapeutically
important drugs for OAB exert their action via inhibition of non-micturition activity
The main study parameters in the male group are to characterize non-micturition activity
during bladder filling, to relate this activity to bladder volume and sensation, to
determine the nature of any change in this activity associated with OAB and assess the
relationship between the OAB symptoms with the amount of obstruction. The secondary study
parameters are to identify possible mechanisms underlying OAB, to explore the possibility
that therapeutically important drugs for OAB exert their action via inhibition of
non-micturition activity.
Nature and extent of burden and risks associated with participation, benefit and group
relatedness: Patients that participate in this study will not be exposed to serious adverse
events and there will be no side effects. The investigation that they undergo for the normal
workup of their complaints will take about ten minutes longer.
The patients will be asked to fill in an extra question list the so called
self-consciousness questionnaire.
Patients will benefit of this study in directly, because it will be helpful in getting
information on non-micturation activity and the relation with sensation. The results
hopefully will lead to a better understanding of the normal and pathological bladder.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
Enrolling by invitation |
NCT06317116 -
Examining the Relationship Between Core Muscles and Bladder Issues in Children
|
||
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Recruiting |
NCT05814614 -
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation
|
N/A | |
Recruiting |
NCT04288427 -
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
|
N/A | |
Not yet recruiting |
NCT06452927 -
EEP in Patients With Urodynamically Proven DU/DA
|
N/A | |
Completed |
NCT02330107 -
Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men
|
N/A | |
Completed |
NCT03339609 -
Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children
|
N/A | |
Terminated |
NCT02003742 -
Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT01078545 -
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
|
N/A | |
Completed |
NCT02074644 -
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
|
N/A | |
Recruiting |
NCT03802851 -
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT05415748 -
Deprescribing Tamsulosin in Older Men
|
Phase 4 | |
Recruiting |
NCT05702294 -
Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .
|
N/A | |
Enrolling by invitation |
NCT05537272 -
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
|
Phase 4 | |
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Completed |
NCT04104100 -
Prevalence and Risk Factor of NP in Women With LUTS
|
||
Completed |
NCT04190641 -
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
|
N/A |